On Friday, GE HealthCare Techs reached a key performance benchmark, with its Relative Strength (RS) Rating moving into the 80-plus percentile with an improvement to 81, up from 71 the day before. Keep in mind this is a new-issue stock, being a recent spin-off.
When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.
IBD's proprietary rating measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the top-performing stocks typically have an 80 or higher RS Rating in the early stages of their moves.
See How IBD Helps You Make More Money In Stocks
GE HealthCare Techs is not currently offering a proper buying opportunity. See if the stock goes on to form a promising consolidation that could launch a move on this recent IPO. A reminder that IPOs are often quite volatile.
Earnings grew -5% last quarter, up from -23% in the prior report. Revenue also increased, from 2% to 6%.
The company earns the No. 12 rank among its peers in the Medical-Systems/Equipment industry group. IDEXX Laboratories and Masimo are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
